Liposeuticals Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
Liposeuticals General Information
Description
Developer of sterile injectable drugs designed to treat anesthesiology, oncology, and infectious diseases. The company's drugs specialize in non-water-soluble that is based on a patented, non-toxic, drug reformulation technology platform, which utilizes pure sugar-lipid polymers that can solubilize compounds and disperse them, enabling healthcare practitioners to reduce drug wastage through vial reuse and enhance stability, reduce costs via extended shelf-life and eliminate antibiotic resistance and toxic recipients.
Contact Information
Website
www.liposeuticals.comCorporate Office
- 11 Deer Park Drive
- Suite 121
- Monmouth Junction, NJ 08852
- United States
Corporate Office
- 11 Deer Park Drive
- Suite 121
- Monmouth Junction, NJ 08852
- United States
Liposeuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Jul-2025 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 03-Mar-2017 | Completed | Generating Revenue | |||
| 1. Grant | 01-Jan-2017 | $150K | Completed | Generating Revenue |
Liposeuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Liposeuticals Patents
Liposeuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10064954-B2 | Polymer-cyclodextrin-lipid conjugates | Active | 23-Jun-2015 | ||
| US-20160375150-A1 | Polymer-cyclodextrin-lipid conjugates | Active | 23-Jun-2015 | ||
| US-10835608-B2 | Polymer-carbohydrate conjugates for drug delivery technology | Active | 05-Dec-2013 | ||
| US-20150157721-A1 | Polymer-carbohydrate conjugates for drug delivery technology | Active | 05-Dec-2013 | ||
| US-20130004592-A1 | Pharmaceutical compositions for parenteral administration | Active | 28-Jun-2011 | A61K47/26 |
Liposeuticals Signals
Liposeuticals FAQs
-
When was Liposeuticals founded?
Liposeuticals was founded in 2011.
-
Where is Liposeuticals headquartered?
Liposeuticals is headquartered in Monmouth Junction, NJ.
-
What is the size of Liposeuticals?
Liposeuticals has 4 total employees.
-
What industry is Liposeuticals in?
Liposeuticals’s primary industry is Drug Discovery.
-
Is Liposeuticals a private or public company?
Liposeuticals is a Private company.
-
What is Liposeuticals’s current revenue?
The current revenue for Liposeuticals is .
-
How much funding has Liposeuticals raised over time?
Liposeuticals has raised $10M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process